Диссертация (1140133), страница 15
Текст из файла (страница 15)
- С. 72-79.74. Abdel-Malek, Z. The melanocortin-1 receptor and human pigmentation / Z.Abdel-Malek [et al.] // Ann. N. Y. Acad. Sci. – 1999. – 885. - P. 117–133.75. Achar, A. Melasma: a clinico-epidemiological study of 312 cases / A. Achar,S.K. Rathi // Indian J Dermatol. – 2011. – 56. – P. 380–382.76. Adalatkhan, H. The Correlation between melasma, ovarian cysts andandrogenic hormones (a case control study) / H.Adalatkhan, F. Amani // ResBiol Sci. – 2007.
– 2. – P. 593–596.77. Anderson, R.R. The optics of human skin / R.R. Anderson, J. Parish // JInvest Dermatol. – 1981. – 77. – P. 13—19.78. Arora, P. Lasers for treatment of melasma and post-inflammatoryhyperpigmentation / P. Arora [et al.] // J Cutan Aesthet Surg. – 2012. – 5.
– P.93-103.79. Bagherani, N. An Overview on Melasma / N. Bagherani, S. Gianfaldoni, B.Smoller // Pigmentary Disorders. – 2015. – 2. – P. 216.80. Bak, H. Increased expression of nerve growth factor receptor and neuralendopeptidase in the lesional skin of melasma. Dermatol / H. Bak [et al.] //Surg. – 2009. – 35. – P. 1244–1250.81. Balina, L.M. The treatment of melisma.
20% azelaic acid versus 4%hydroquinone cream / L.M. Balina, K. Graupe // Int J Dermatol. - 1991. – 30(12). – P. 893–5.82. Barcauí, C.B. Classificação do melasma pela dermatoscopia: estudocomparativo com lâmpada de Wood / C.B. Barcaui [et al.] // Surg CosmDermatol. – 2009. – 1. – P. 115-9.9683. Bissett, D.L. Reduction in the appearance of facial hyperpigmentation bytopical N-acetyl glucosamine / D.L. Bissett [et al.] // J Cosmet Dermatol. –2007. – 6. – P.
20-26.84. Boissy, R.E. The melanocyte. Its structure, function, and subpopulations inskin, eyes, and hair / R. E. Boissy // Dermatol Clin. – 1988. – 6. – P. 161-73.85. Bolanca, I. Chloasma-the mask of pregnancy / I. Bolanca [et al.] // CollAntropol. – 2008. - 32 (2). – P. 139-141.86. Briganti, S. Chemical and instrumental approaches to treat hyperpigmentation// S. Briganti, E. Camera, M. Picardo // Pigment Cell Res. – 2003. – 16 (2).
–P. 101–10.87. Bukvic Mokos, Z. Laser therapy of pigmented lesions: pro and contra / Z.Bukvic Mokos [et al.] // Acta Dermatovenerol Croat. – 2010. – 18. – P. 185189.88. Castanedo-Cazares, J.P. Near-visible light and UV photoprotection in thetreatment of melasma: a double-blind randomized trial / J.P. CastanedoCazares // Photodermatol Photoimmunol Photomed. - 2014. – 30. – P. 35-42.89. Cestari, T. Melasma in Latin America: options for therapy and treatmentalgorithm / T.
Cestari [et al.] // J Eur Acad Dermatol Venereol. – 2009. – 23. P. 760-772.90. Chakraborty, A.K. UV light and MSH receptors / A.K. Chakraborty [et al.] //Ann. N. Y. Acad. Sci. – 1999. – 885. – P. 100–116.91. Chan, R. A randomized controlled trial of the efficacy and safety of a fixedtriple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin0.05%) compared with hydroquinone 4% cream in Asian patients withmoderate to severe melisma / R. Chan [et al.] // Br J Dermatol. – 2008.
– 159(3). – P. 697–703.92. Chompootaweep, S. Effectiveness of Norplant implants among Thai womenin Bangkok / S. Chompootaweep [et al.] // Contraception. – 1996. – 53. – P.33–36.9793. Corsi, H. Chloasma Virginum Periorale / H. Corsi // Proc R Soc Med. – 1935.– 28. – P. 1169.94. Costin, G.E. Human skin pigmentation: melanocytes modulate skin color inresponse to stress / G.E.
Costin, V.J. Hearing // FASEB J. – 2007. - 21(4). –P. 976-94.95. Dessinioti, C. Melasma / C. Dessinioti, A. Pavlidis, A.D. Katsambas //Pigmentary Disorders. – 2014. – 1. - P. 1.96. Draelos, Z.D. Skin lightening preparations and the hydroquinone controversy/ Z.D. Draelos // Dermatol Ther.
– 2007. – 20 (5). – P. 308–13.97. Duarte, I. Frequency of dermatoses associated with cosmetics / I. Duarte, A.C. Campos Lage // Contact Dermatitis. – 2007. – 56. – P. 211–213.98. Dunn, C.J. Tranexamic acid: A review of its use in surgery and otherindications / C.J. Dunn, K.L. Goa // Drugs. – 1999. – 57. – P. 1005–32.99.
Elling, S.V. Physiological changes in the skin during pregnancy / S.V. Elling,F.C. Powell // Clin Dermatol. – 1997. – 15. – P. 35–43.100. Ertam, I. Efficiency of ellagic acid and arbutin in melasma: a randomized,prospective, openlabel study / I. Eratam [et al.] // J Dermatol. – 2008.
– 35. –P. 570-574.101. Espinal-Perez, L.E. A doubleblind randomized trial of 5% ascorbic acid vs.4% hydroquinone in melisma / L.E. Espinal-Perez, B. Moncada, J.P.Castanedo-Cazares // Int J Dermatol. – 2004. – 43. – P. 604-607.102. Famenini, S. Finasteride associated melasma in a caucasian male / S.Famenini, N.M. Gharavi, D.P. Beynet // J. Drugs Dermatol. – 2004. – 13.
– P.484–486.103. Ferrara, N. Binding to the extracellular matrix and proteolytic processing: twokey mechanisms regulating vascular endothelial growth factor action / N.Ferrara // Mol Biol Cell. – 2010. – 21. – P. 687-690.104. Fisk, W.A. The use of botanically derived agents for hyperpigmentation: asystematic review / W.A. Fisk [et al.] // J Am Acad Dermatol. – 2014. – 70. –P. 352-365.98105. Foldes, E.G. Pharmaceutical effect of contraceptive pills on the skin / E. G.Foldes // Int. J. Clin.
Pharmacol. Ther. Toxicol. – 1988. – 26. – P. 356–359.106. Freeman, D.A. Finasteride blocks progesterone synthesis in MA-10 Leydigtumor cells / D.A. Freeman, P.M. Gocze, Z. Porpaczy // Endocrinology. –1993. – 133. – P. 1915–1917.107. Garg, V.K. Comparative evaluation of beneficiary effects of priming agents(2% hydroquinone and 0.025% retinoic acid) in the treatment of melasmawith glycolic acid peels / V.K.
Gark, R. Sarkar // Dermatol Surg. – 2008. –34. – P. 1032-1039.108. Gilchrest, B.A. Mechanisms of ultraviolet light-induced pigmentation / B.A.Gilchrest [et al.] // Photochem. Photobiol. – 1996. – 63. – P. 1–10.109. Gillbro, J.M. The melanogenesis and mechanisms of skin-lightening agentsexisting and new approaches / J.M. Gillbro, M.J. Olsson // Int J Cosmet Sci.
–2011. – 33. – P. 210-221.110. Godse, K.V. Triple combination of hydroquinone, tretinoin and mometasonefuroate with glycolic acid peels in melasma / K.V. Godse // Indian JDermatol. – 2009. – 54 (1). – P. 92–3.111. Goh, C.L. A retrospective study on the clinical presentation and treatmentoutcome of melasma in a tertiary dermatological referral centre in Singapore /C.L.
Goh, C.N. Dlova // Singapore Med J. – 1999. – 40. – P. 455–458.112. Guinot, C. Aggravating factors for melasma: a prospective study in 197Tunisian patients / C. Guinot [et al.] // J Eur Acad Dermatol Venereol. – 2010.– 24. – P.1060-1069.113. Hakozaki, T.
The effect of niacinamide on reducing cutaneous pigmentationand suppression of melanosome transfer / T. Hakozaki [et al.] // Br JDermatol. – 2002. – 147. – P. 20-31.114. Handel, A.C. Melasma: a clinical and epidemiological review / A.C. Handel,L.D. Miot, H.A. Miot // An Bras Dermatol. – 2014. – 89 (5). – P. 771-82.115. Handel, A.C.Risk factors for facial melasma in women: a case–control study /A.C.
Handel [et al.] // Br. J. Dermatol. – 2014. - 171. - P. 588–594.99116. Hassan, I. Hormonal milieu in the maintenance of melasma in fertile women /I. Hassan [et al.] // J Dermatol. – 1998. – 25. – P. 510–512.117. Hayakawa, R. Effects of combination treatment with vitamins E and C onchloasma and pigmented contact dermatitis. A double blind controlled clinicaltrial / R.
Hayakawa [et al.] // Acta Vitaminol Enzymol. – 1981. – 3. – P. 3138.118. Hexsel, D. Epidemiology of melasma in Brazilian patients: a multicenterstudy / D. Hexsel [et al.] // Int J Dermatol. – 2014. – 53. – P. 440-444.119. Im, S. Donor specific response of estrogen and progesterone on culturedhuman melanocytes / S. Im [et al.] // J Korean Med Sci. – 2002.
– 17. - P. 58–64.120. Im, S. Increased expression of alpha-melanocyte-stimulating hormone in thelesional skin of melisma / S. Im [et al.] // Br. J. Dermatol. – 2002. – 146. – P.165–167.121. Imokawa, G. Autocrine and paracrine regulation of melanocytes in humanskin and in pigmentary disorders / G. Imokawa // Pigment Cell Res. – 2004. 17(2).
– P. 96-110.122. Imokawa, G. Endothelin-1 as a new melanogen: coordinated expression of itsgene and the tyrosinase gene in UVB-exposed human epidermis / G.Imokawa, M. Miyagishi, Y. Yada // J. Invest. Dermatol. – 1995. – 105. – P.32–37.123. Jang, Y.H. Oestrogen and progesterone receptor expression in melasma: animmunohistochemical analysis / Y.H.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
